2017年乌克兰儿童白喉和破伤风血清流行病学调查
2017年在乌克兰四个地区对2006-2015年出生儿童开展血清学调查,检测白喉和破伤风IgG抗体。所有调查点白喉抗体≥0.1 IU/mL的血清流行率均<80%(50.0%-79.2%),破伤风抗体≥0.1 IU/mL在苏梅、基辅市和敖德萨≥80%(80.2%-89.1%),外喀尔巴阡为61.6%。适龄接种含白喉-破伤风疫苗的比例为28.5%-57.4%(2006-2010年出生)和34.1%-54.3%(2011-2015年出生)。
要点
- 所有调查点白喉抗体≥0.1 IU/mL的血清流行率均<80%(50.0%-79.2%)。
- 破伤风抗体≥0.1 IU/mL在外喀尔巴阡为61.6%,其余三地≥80%(80.2%-89.1%)。
- 2006-2015年出生儿童的白喉-破伤风免疫状态在所有调查点均不理想。
核心结论
- 2006-2015年出生儿童对白喉的保护不理想(<80%),尤其在外喀尔巴阡。
- 除外喀尔巴阡外,破伤风保护充足(≥80%)。
- 所有调查点的白喉-破伤风免疫状态均不理想。
- 作者建议对未接种/接种不足儿童开展补种接种及其他提高免疫覆盖的努力,以缩小免疫差距并防止乌克兰白喉和破伤风复燃,尤其在外喀尔巴阡。
研究设计与样本
- 2017年对2006-2015年出生儿童开展血清学调查,检测标本来自2015年外喀尔巴阡省1型循环疫苗衍生脊髓灰质炎病毒疫情后全国暴发应对免疫所针对的出生队列。
- 调查乌克兰四个地区:外喀尔巴阡、苏梅和敖德萨省采用整群抽样,基辅市采用简单随机抽样。
- 采用微珠法(MBA)检测血清白喉和破伤风IgG抗体,估计血清流行率并计算95%置信区间,同时获取受调查儿童的免疫接种状态信息。
主要发现
- 白喉抗体≥0.1 IU/mL的血清流行率在所有调查点均<80%(50.0%-79.2%)。
- 破伤风抗体≥0.1 IU/mL的血清流行率在苏梅、基辅市和敖德萨为80.2%-89.1%,在外喀尔巴阡为61.6%。
- 适龄接种含白喉-破伤风疫苗(DTCV)的比例在2006-2010年出生儿童中为28.5%-57.4%,在2011-2015年出生儿童中为34.1%-54.3%。
- 接种<3剂DTCV的比例从2006-2010年出生儿童的7.1%-16.7%上升至2011-2015年出生儿童的19.8%-38.6%。
- 接种零剂DTCV的比例从2006-2010年出生儿童的2.6%-8.8%上升至2011-2015年出生儿童的8.0%-14.0%。
关键数值与推荐
- 白喉抗体血清流行率阈值:≥0.1 IU/mL。
- 破伤风抗体血清流行率阈值:≥0.1 IU/mL。
- 白喉保护判定:血清流行率<80%为不理想。
- 破伤风保护判定:血清流行率≥80%为充足。
临床怎么用
- 作者建议对未接种/接种不足儿童开展补种接种及其他提高免疫覆盖的努力,以缩小免疫差距并防止乌克兰白喉和破伤风复燃,尤其在外喀尔巴阡。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The drastic decline of Ukraine's immunization coverage since 2009 led to concerns about potential resurgence diphtheria and tetanus, along with other vaccine-preventable diseases. METHODS: To assess population immunity against diphtheria and tetanus, we tested specimens from the serosurvey conducted in 2017 among children born in 2006-2015, the birth cohorts targeted by the nationwide outbreak response immunization following a circulating vaccine-derived poliovirus type 1 outbreak in Zakarpattya province in 2015. We surveyed four regions of Ukraine, using cluster sampling in Zakarpattya, Sumy, and Odessa provinces and simple random sampling in Kyiv City. We tested serum specimens for IgG antibodies against diphtheria and tetanus, using microbead assays (MBA). We estimated seroprevalence and calculated 95% confidence intervals. We also obtained information on the immunization status of surveyed children. RESULTS: Seroprevalence of ≥0.1 IU/mL diphtheria antibodies was <80% in all survey sites (50.0%-79.2%). Seroprevalence of ≥0.1 IU/mL tetanus antibodies was ≥80% in Sumy, Kyiv City, and Odessa (80.2%-89.1%) and 61.6% in Zakarpattya. Across the sites, the proportion of children vaccinated age-appropriately with diphtheria-tetanus-containing vaccines (DTCV) was 28.5%-57.4% among children born in 2006-2010 and 34.1%-54.3% among children born in 2011-2015. The proportion of recipients of <3 DTCV doses increased from 7.1%-16.7% among children born in 2006-2010 to 19.8%-38.6% among children born in 2011-2015, as did the proportion of recipients of zero DTCV doses (2.6%-8.8% versus 8.0%-14.0%, respectively). CONCLUSIONS: Protection against diphtheria among children born in 2006-2015 was suboptimal (<80%), particularly in Zakarpattya. Protection against tetanus was adequate (≥80%) except in Zakarpattya. Diphtheria-tetanus immunization status was suboptimal across all sites. Catch-up vaccination of unvaccinated/under-vaccinated children and other efforts to increase immunization coverage would close these immunity gaps and prevent the resurgence of diphtheria and tetanus in Ukraine, particularly in Zakarpattya.
引用
- Khetsuriani N, Zaika O, Slobodianyk L, et al. Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017. Vaccine. 2022. PMID: 35153095. doi:10.1016/j.vaccine.2022.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。